Trial Profile
Randomized Trial of Short Antibiotic Course to Decrease Post ERCP Cholangitis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2023
Price :
$35
*
At a glance
- Drugs Ceftriaxone (Primary) ; Levofloxacin (Primary)
- Indications Cholangitis
- Focus Therapeutic Use
- 02 Mar 2023 Planned End Date changed from 23 Feb 2023 to 23 Feb 2024.
- 02 Mar 2023 Planned primary completion date changed from 23 Feb 2023 to 23 Feb 2024.
- 06 Dec 2021 Planned End Date changed from 23 Feb 2021 to 23 Feb 2023.